FIELD: medicine.
SUBSTANCE: invention relates to medicine and is a method for evaluating embryo implantation disorders at the early stage of pregnancy up to 12 weeks complicated by cytomegalovirus infection, consisting in the study of homogenate of villous chorion by immunoassay, where the COX-2 content is determined in the villous chorion homogenate, and the COX-2 value is more than 16.85 ng/ml, the embryo implantation disorder is stated.
EFFECT: invention provides the possibility to establish a risk factor threatening pregnancy course, and its interruption at early stages.
1 cl, 2 ex, 1 tbl
Authors
Dates
2019-04-22—Published
2018-05-07—Filed